Matches in Wikidata for { <http://www.wikidata.org/entity/Q83944945> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q83944945 description "article scientifique publié en 2012" @default.
- Q83944945 description "artículu científicu espublizáu en mayu de 2012" @default.
- Q83944945 description "im Mai 2012 veröffentlichter wissenschaftlicher Artikel" @default.
- Q83944945 description "scientific article published on 01 May 2012" @default.
- Q83944945 description "wetenschappelijk artikel" @default.
- Q83944945 description "наукова стаття, опублікована в травні 2012" @default.
- Q83944945 name "Lysophosphatidic acid pretreatment prevents micromolar atorvastatin-induced endothelial cell death and ensures the beneficial effects of high-concentration statin therapy on endothelial gene expression" @default.
- Q83944945 name "Lysophosphatidic acid pretreatment prevents micromolar atorvastatin-induced endothelial cell death and ensures the beneficial effects of high-concentration statin therapy on endothelial gene expression" @default.
- Q83944945 type Item @default.
- Q83944945 label "Lysophosphatidic acid pretreatment prevents micromolar atorvastatin-induced endothelial cell death and ensures the beneficial effects of high-concentration statin therapy on endothelial gene expression" @default.
- Q83944945 label "Lysophosphatidic acid pretreatment prevents micromolar atorvastatin-induced endothelial cell death and ensures the beneficial effects of high-concentration statin therapy on endothelial gene expression" @default.
- Q83944945 prefLabel "Lysophosphatidic acid pretreatment prevents micromolar atorvastatin-induced endothelial cell death and ensures the beneficial effects of high-concentration statin therapy on endothelial gene expression" @default.
- Q83944945 prefLabel "Lysophosphatidic acid pretreatment prevents micromolar atorvastatin-induced endothelial cell death and ensures the beneficial effects of high-concentration statin therapy on endothelial gene expression" @default.
- Q83944945 P1433 Q83944945-F2071C53-594F-4A1E-AD56-78A64ADCF9E8 @default.
- Q83944945 P1476 Q83944945-91F536CD-B206-422B-A7CF-49D998219794 @default.
- Q83944945 P2093 Q83944945-21EE8DCC-5BBB-4D6F-976A-3A081E6E9822 @default.
- Q83944945 P2093 Q83944945-5CA52447-3F19-43C6-8A2A-7640DC3237E2 @default.
- Q83944945 P2093 Q83944945-D9F2920D-E7AF-4949-83EF-60958E531139 @default.
- Q83944945 P304 Q83944945-998442F4-7BEC-4F01-B15E-1D486AACBF07 @default.
- Q83944945 P31 Q83944945-CC2414A7-EF64-429E-A264-0F4D71892095 @default.
- Q83944945 P356 Q83944945-1633A666-B937-4CA0-8C14-EB5F96AF8CB2 @default.
- Q83944945 P433 Q83944945-FEC226D2-6895-4532-9C4B-FA9739E44A23 @default.
- Q83944945 P478 Q83944945-5E31843B-B007-43DC-B2A9-8B9A0CDAC4CC @default.
- Q83944945 P50 Q83944945-34C2EF5B-8040-4188-9683-494484322C2D @default.
- Q83944945 P50 Q83944945-749BFC11-5D42-4CA4-9F56-1B38C8CF6789 @default.
- Q83944945 P577 Q83944945-A04DEADA-7A93-4522-A4CA-4CE6667C02BC @default.
- Q83944945 P698 Q83944945-F1078984-FFC6-48BA-9B7A-BBCC6389270C @default.
- Q83944945 P921 Q83944945-D671CEB3-BF37-48C5-A482-2407CC7DD2BF @default.
- Q83944945 P356 J.AVSG.2012.01.005 @default.
- Q83944945 P698 22520393 @default.
- Q83944945 P1433 Q15751634 @default.
- Q83944945 P1476 "Lysophosphatidic acid pretreatment prevents micromolar atorvastatin-induced endothelial cell death and ensures the beneficial effects of high-concentration statin therapy on endothelial gene expression" @default.
- Q83944945 P2093 "Indalecio Sánchez-Montesinos" @default.
- Q83944945 P2093 "Maria Esteban" @default.
- Q83944945 P2093 "Olga Roda" @default.
- Q83944945 P304 "549-558" @default.
- Q83944945 P31 Q13442814 @default.
- Q83944945 P356 "10.1016/J.AVSG.2012.01.005" @default.
- Q83944945 P433 "4" @default.
- Q83944945 P478 "26" @default.
- Q83944945 P50 Q57014203 @default.
- Q83944945 P50 Q83461478 @default.
- Q83944945 P577 "2012-05-01T00:00:00Z" @default.
- Q83944945 P698 "22520393" @default.
- Q83944945 P921 Q2383867 @default.